Aspira Women's Health Inc. Income Statement
AWHL|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$343,000
FY2025
Gross Profit
$6M
1724.5% gross margin
Operating Income
-$8M
FY2025
Net Income
-$13M
FY2025
Aspira Women's Health Inc. reported $343,000 in revenue and $13M in net loss for FY2025. Revenue has declined at a 11.6% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -89.08 (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $343.0K | $4.0K | $87.0M | $8.2M | $6.8M | $4.7M | $4.5M | $3.1M | $3.1M | $2.6M | $2.2M | $2.5M | $2.6M | $2.1M | $1.9M |
| Cost of Revenue | $3.3M | $3.7M | $3.9M | $3.9M | $3.8M | $3.4M | $3.3M | $3.1M | $2.9M | $2.7M | $2.3M | $1.2M | $170.0K | $131.0K | $129.0K |
| Gross Profit | $5.9M | $5.5M | $5.3M | $4.3M | $3.1M | $1.2M | $1.2M | -$89.0K | $207.0K | -$56.0K | -$132.0K | $1.3M | $2.4M | $2.0M | $1.8M |
| SG&A Expense | $8.0M | $10.3M | $12.3M | $14.6M | $13.3M | $8.3M | $5.8M | $5.1M | $5.5M | $5.9M | $5.5M | $5.9M | $4.2M | $4.5M | $8.5M |
| R&D Expense | $2.9M | $3.3M | $4.0M | $5.9M | $5.3M | $2.1M | $1.0M | $550.0K | $837.0K | $2.2M | $3.8M | $4.7M | $2.6M | $2.2M | $5.4M |
| Operating Income | -$7.9M | -$16.3M | -$18.9M | -$31.1M | -$32.6M | -$18.0M | -$15.3M | -$11.3M | -$10.4M | -$15.0M | -$19.2M | -$19.2M | -$8.9M | -$9.4M | -$17.6M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | $206.0K | $396.0K |
| Income Tax | - | - | - | - | - | $0 | $0 | $0 | $0 | $0 | $0 | - | - | - | - |
| Net Income | -$12.8M | -$13.1M | -$16.7M | -$29.9M | -$31.7M | -$17.9M | -$15.2M | -$11.4M | -$10.5M | -$15.0M | -$19.1M | -$19.2M | -$8.8M | -$7.1M | -$17.8M |
| EPS (Basic) | -$0.93 | -$1.81 | -$3.85 | -$0.28 | -$0.18 | -$0.18 | -$0.16 | -$0.20 | -$0.29 | -$0.41 | -$0.53 | -$0.42 | -$0.48 | - | - |
| EPS (Diluted) | -$0.93 | -$1.81 | -$3.85 | -$0.28 | -$0.18 | -$0.18 | -$0.16 | -$0.20 | -$0.29 | -$0.41 | -$0.53 | -$0.42 | -$0.48 | -$1.25 | -$1.83 |
| Shares Outstanding | 17.4M | 10.6M | 8.3M | 7.5M | 104.6M | 97.3M | 75.5M | 60.0M | 52.3M | 52.1M | 43.1M | 35.8M | 15.2M | 14.9M | 10.7M |
| Gross Margin | 1724.5% | 136975.0% | 6.0% | 52.8% | 45.0% | 26.6% | 26.3% | -2.9% | 6.6% | -2.1% | -6.1% | 51.2% | 93.4% | 93.7% | 93.3% |
| Operating Margin | -2307.0% | -406950.0% | -21.7% | -380.5% | -478.5% | -386.6% | -336.7% | -371.2% | -334.5% | -566.0% | -884.2% | -762.0% | -345.4% | -449.6% | -917.4% |
| Profit Margin | -3726.0% | -327350.0% | -19.2% | -365.2% | -464.8% | -385.0% | -335.8% | -372.4% | -336.3% | -566.5% | -878.0% | -762.0% | -343.7% | -341.3% | -925.1% |